Skip to main content
Welcome to
super saver spring
offer ends april 20
save over $140
save over 85%
$0.99
per week for 24 weeks
Welcome to
super saver spring
$0.99
per week
for 24 weeks
// //

Perimeter Medical Imaging Ai Inc TSX Venture: PINK-X

Today's Change
Volume
Real-Time Last Update TSX Venture Last Sale

Today's Trading

Day Low 4.020
Day High 4.210
Open:4.200
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Perimeter Medical Imaging AI Inc is a medical device company. It is engaged in developing and commercializing advanced in-procedural medical imaging tools. The firm's OTIS platform is an FDA-cleared point-of-care imaging system. It provides clinicians with real-time, ultra-high-resolution, sub-surface image volumes of the margin (1-2 mm below the surface) of an excised tissue specimen.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

No rating

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Latest Press Releases

Clinical Trials Critical for the Evaluation of Advanced Medical Imaging Tools
- PR Newswire - PRF - Wed Apr 14, 7:50AM CDT
PR Newswire - PRF - CMTX
Wed Apr 14, 7:50AM CDT
, /PRNewswire/ -- Image-guided surgery offers surgeons greater control of the procedure and real-time feedback, thus providing better outcomes for patients. Accuracy in surgical procedures is critical for serious or life-threatening conditions, such as cancer, and medical technology companies are providing imaging tools to help surgeons deliver better results to their patients. Companies such as (TSXV:PINK),(NYSE:BFLY),(NASDAQ:NDRA),(NYSE:ASXC), and (NASDAQ:AVGR) have engaged in the research and development of advanced imaging tools for use in different procedures. In addition to the development of these tools, these companies are seeking regulatory approval and collaborating in clinical studies that provide data on the application of these imaging tools.
Perimeter Medical Imaging AI Announces Important Milestone in ATLAS AI Project with Standalone AI Algorithm Achieving Key Performance Metrics
- BusinessWire - Wed Apr 14, 7:45AM CDT
BusinessWire - CMTX
Wed Apr 14, 7:45AM CDT
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) ("Perimeter" or the "Company"), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today announced significant progress within its ATLAS AI Project, an initiative aimed at advancing Perimeter's next-gen artificial intelligence (AI) and machine learning tools through clinical development. Perimeter's proprietary "ImgAssist" AI technology has now been trained with more than 400 volumes of images of excised breast tissue collected during the first stage of its ATLAS AI project.
Rising Demand for Diagnostic Tools Fuels the Growing Medical Imaging Market
- PR Newswire - PRF - Tue Apr 6, 7:50AM CDT
PR Newswire - PRF - CMTX
Tue Apr 6, 7:50AM CDT
, /PRNewswire/ -- Medical diagnostic and imaging tools have played a critical role in the detection and early diagnosis of diseases such as cancer, which are less treatable in their later stages. The medical imaging and diagnostics industry is set to grow significantly in the future as more companies embrace artificial intelligence (AI) and machine learning (ML) in the design and development of their medical imaging and diagnostic tools. With the industry likely to grow to by 2027, top medical imaging device manufacturers like (TSXV:PINK) (OTCPK:PYNKF),(NASDAQ:HOLX),(NYSE:SYK),(NASDAQ:NNOX), and (NYSE:GE) are taking note and developing point-of-care diagnostic tools for the US market. Such tools improve the speed and efficiency of diagnosis by delivering results immediately rather than later.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 3.670 +14.44% increase
on 04/12/21
Period Open:4.760
Price movement based on the high, low and last over the given period.
4.840 -13.22% decrease
on 03/17/21
-0.560 (-11.76%) decrease
since 03/16/21
3-Month 2.700 +55.56% increase
on 01/27/21
Period Open:3.090
Price movement based on the high, low and last over the given period.
4.840 -13.22% decrease
on 03/17/21
+1.110 (+35.92%) increase
since 01/15/21
52-Week 1.460 +187.67% increase
on 07/20/20
Period Open:1.710
Price movement based on the high, low and last over the given period.
4.840 -13.22% decrease
on 03/17/21
+2.490 (+145.61%) increase
since 07/06/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies